Evidence map›Paper›PMID 33095882›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Respiratory Syncytial Virus Disease Severity in Young Children.

Zaid Haddadin, Stockton Beveridge, Kailee Fernandez, Danielle A Rankin, Varvara Probst, Andrew J Spieker, Tiffanie M Markus, Laura S Stewart, William Schaffner, Mary Lou Lindegren and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zaid HaddadinDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0001-6863-6185
Stockton BeveridgeDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kailee FernandezDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Danielle A RankinDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Varvara ProbstDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andrew J SpiekerDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tiffanie M MarkusDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Laura S StewartDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
William SchaffnerDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mary Lou LindegrenDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Natasha HalasaDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USThe University of Texas Southwestern Medical Center · USVanderbilt University · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
NRSA Training CoreTL1TR002244 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$4.6M
Centers for Disease Control and Prevention Emerging Infections Program Cooperative Agreement 1U50CK000491NCATS NIH HHS TL1 TR002244NCATS NIH HHS UL1 TR000445
6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) is the leading cause of acute respiratory infections (ARIs) in hospitalized children. Although prematurity and underlying medical conditions are known risk factors, most of these children are healthy, and factors including RSV load and subgroups may contribute to severity. Therefore, we aimed to evaluate the role of RSV in ARI severity and determine factors associated with increased RSV-ARI severity in young children.

methodsChildren aged <5 years with fever and/or ARI symptoms were recruited from the emergency department (ED) or inpatient settings at Vanderbilt Children's Hospital. Nasal and/or throat swabs were tested using quantitative reverse-transcription polymerase chain reaction for common respiratory viruses, including RSV. A severity score was calculated for RSV-positive children.

resultsFrom November 2015 through July 2016, 898 participants were enrolled, and 681 (76%) had at least 1 virus detected, with 191 (28%) testing positive for RSV. RSV-positive children were more likely to be hospitalized, require intensive care unit admission, and receive oxygen compared with children positive for other viruses. Higher viral load, White race, younger age, and higher severity score were independently associated with hospitalization in RSV-positive children. No differences in disease severity were noted between RSV A and RSV B.

conclusionsRSV was associated with increased ARI severity in young children enrolled from the ED and inpatient settings, but no differences in disease severity were noted between RSV A and RSV B. These findings emphasize the need for antiviral therapy and/or preventive measures such as vaccines against RSV in young children.

Indexed as

Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsChildChild, PreschoolHospitalizationHumansInfantProspective StudiesSeverity of Illness Indexacute respiratory infectionschildrenrespiratory syncytial virusrespiratory syncytial virus subgroupsseverity score

Identifiers

PMID33095882
PMCPMC8826377
OpenAlexW3094280318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.